Digitoxin
(Crystodigin)
Category:
Description:
Indications:
-
Congestive
heart failure, atrial fibrillation, atrial flutter
-
Paroxysmal
atrial tachycardia (PAT)
-
Cardiogenic
shock
Contraindications:
-
Ventricular
tachycardia
-
Ventricular
fibrillation
Precautions:
-
Pregnancy
category C; passes readily into fetus; excretion into breast milk
unknown
-
Hypokalemia,
hypomagnesemia, hypercalcemia, hypothyroidism, sick sinus syndrome
-
Severe
pulmonary disease, hepatic disease, AV block, acute MI, hepatic
disease
-
Wolff-Parkinson-White
syndrome
Adverse
Reactions (Side Effects):
-
CNS:
anorexia, apathy, confusion, delirium, disorientation, drowsiness, EEG
abnormalities, hallucinations, headache, mental depression, neuralgia,
psychosis, restlessness, seizures, weakness
-
CV:
atrial fibrillation, AV block, bradycardia, premature ventricular
contractions (PVC’s), ventricular fibrillation, ventricular
tachycardia
-
EENT:
visual disturbances (blurred, yellow or green halo effect)
-
GI:
abdominal discomfort, diarrhea, hemorrhagic necrosis of the
intestines, nausea, vomiting
-
HEME:
eosinophilia, thrombocytopenia
-
SKIN:
rash
|
Dosage:
Administered
orally (tablet)
-
Adult: Loading dose PO (rapid) 0.6mg, followed by 0.4mg, then 0.2mg at
every 4-6 hour intervals; (slow) 0.2mg 2 times daily for 4 days;
maintenance dose PO 0.05-0.3mg daily. Dosage reduction not needed in renal function impairment
-
Child: Loading dose PO <1 year 0.045 mg/kg, 1-2 years 0.04 mg/kg,
>2 years 0.03 mg/kg divided into 3, 4, or more portions with >6
hours between doses; maintenance dose PO 1/10 loading dose
Drug
interactions:
-
Alprazolam,
amiodarone, diltiazem, verapamil, bepridil, nitrendipine, quinidine,
carvedilol, cyclosporine, erythromycin and tetracycline (change in
bacterial flora causing effect may persist for months),
hydroxychloroquine, NSAIDS, azole antifungals, omeprazole,
lansoprazole, propafenone, quinine, spironolactone, tacrolimus: May cause increased digoxin levels
-
Charcoal:
reduced digitalis levels
-
Beta-Blockers:
Potentiation of bradycardia
-
Succinylcholine:
increased arrhythmias
Special
considerations:
-
Listed
adverse effects are mostly signs of toxicity
-
When
digitalis indicated digoxin is 1st line drug because of shorter ½-life and faster clearance in
the event toxicity develops.
-
Rule
out digitalis toxicity if nausea, vomiting, or arrhythmias develop
-
Therapeutic
range: 9-25 ng/ml
|
Home
· Military Medicine
· Sick Call · Basic Exams
· Medical Procedures
· Lab and X-ray · The Pharmacy
· The Library · Equipment
· Patient Transport
· Medical Force
Protection · Operational Safety · Operational
Settings · Special
Operations · Humanitarian
Missions · Instructions/Orders · Other Agencies · Video Gallery
· Forms · Web Links · Acknowledgements
· Help · Feedback Approved for public release;
Distribution is unlimited. The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks.
Source: Operational Medicine 2001, Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300.
Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300 |
Operational Medicine
Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
January 1, 2001 |
United States Special Operations
Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323 |
*This web version is provided by The Brookside Associates, LLC. It contains
original contents from the official US Navy NAVMED P-5139, but has been
reformatted for web access and includes advertising and links that were not
present in the original version. The medical information presented was reviewed and felt to be accurate in 2001. Medical knowledge and practice methods may have changed since that time. Some links may no longer be active. This web version has not been approved by the
Department of the Navy or the Department of Defense. The presence of any
advertising on these pages does not constitute an endorsement of that product or
service by either the US Department of Defense or the Brookside Associates. The
Brookside Associates is a private organization, not affiliated with the United
States Department of Defense.
© 2015, Brookside Associates, LLC. All rights reserved
Other Brookside Products
|
|